Successful Treatment of Ultrasound-confirmed Synovitis in Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis with Corticosteroid Therapy.
CADM
anti-MDA5 antibody
synovitis
ultrasound
Journal
Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241
Informations de publication
Date de publication:
2024
2024
Historique:
medline:
16
5
2024
pubmed:
16
5
2024
entrez:
15
5
2024
Statut:
ppublish
Résumé
Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive clinically amyopathic dermatomyositis (CADM) is a subtype of dermatomyositis without severe myositis but with characteristic cutaneous manifestations and severe interstitial lung disease. Joint symptoms can occur in patients with anti-MDA5 antibody-positive CADM. However, the treatment strategy and utility of ultrasound for treating joint symptoms remain unknown. We herein report an 85-year-old man with anti-MDA5 antibody-positive CADM who presented with ultrasound-confirmed synovitis that improved with medium-dose corticosteroid therapy.
Identifiants
pubmed: 38749761
doi: 10.2169/internalmedicine.2382-23
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM